References
- Bickel M. H. Pharmac. Rev. 1969; 21: 325
- Boyland E., Manson D., Nery R. J. chem. Soc. 1962; 606
- Brent D. H. J. Am. Ass. Oil Chemists 1976; 59: 1006
- Brent D. H., de Miranda P., Schulten H. R. J. Pharm. Sci. 1974; 63: 1370
- Cowan D. A., Huizing G., Beckett A. H. Xenobiotica 1976; 6: 605
- Cramer J. W., Miller J. A., Miller E. C. J. biol. Chem. 1960; 235: 885
- Elliot P. N. C., Jenner P., Huizing G., Marsden C. D., Miller R. Neuropharmacology 1977; 16: 333
- Forrester A. R., Ogilvy M. M., Thomson R. H. J. chem. Soc. C 1970; 1081
- Fries W., Kiese M., Lenk W. Xenobiotica 1973; 3: 525
- Hamer J., Macaluso A. Chem. Rev. 1964; 64: 473
- Hinson J. A., Mitchell J. R., Jollow D. J. Biochem. Pharmac. 1976; 25: 599
- Huizing G., Beckett A. H., Segura J. J. Chromatogr. 1979a; 172: 227
- Huizing G., Beckett A. H., Segura J. Pharm. Weekbl. Sci. Ed. 1979b; 1: 64
- Huizing G., Beckett A. H., Segura J. J. Pharm. Pharmac. 1980, in the press
- Huizing G., Beckett A. H., Segura J., Bakke O. M. Xenobiotica 1980; 10: 211
- Jenner P., Elliot P. N. C., Clow A., Reavill C., Marsden C. D. J. Pharm. Pharmac. 1978; 30: 46
- Kirk M. C., Coburn W. C., Piper J. R. Biomed. Mass Spectrom. 1976; 3: 245
- Lindeke B., Cho A. K., Thomas T. L., Michelson L. Acta Pharm. Suecica 1973; 10: 493
- Magistretti P., Schorderet M. Naunyn-Schmiedeberg's Arch. Pharmac. 1978; 303: 189
- Masso J. L., Colombo M., Roberts D. J. Arch. Farmac. Tox. 1978; 4: 181
- Mishra R. K. Eur. J. Pharmac. 1978; 51: 189
- Roberts D. J., Salazar W., Beckett P. R., Namorsu S. R. Arch. Farmac. Tox. 1978; 4: 102
- Salazar W., Colombo M., Llupia J., Roberts D. J. Arch. Farmac. Tox. 1978; 4: 60
- Schulten H. R. Biomed. Mass Spectrom. 1974; 1: 223
- Schulten H. R. Cancer Treatment Reports 1976; 60: 501
- Schulten H. R., Games D. E. Biomed. Mass Spectrom. 1974; 1: 120
- Weisburger J. H., Weisburger E. K. Pharmac. Rev. 1973; 25: 1
- Wilson J. M. Mass Spectrometry, R. A. W. Johnstone. The Chemical Society, London 1977; vol. 4